Correlation Between Xenetic Biosciences and Neximmune

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Xenetic Biosciences and Neximmune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xenetic Biosciences and Neximmune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Xenetic Biosciences and Neximmune, you can compare the effects of market volatilities on Xenetic Biosciences and Neximmune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xenetic Biosciences with a short position of Neximmune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xenetic Biosciences and Neximmune.

Diversification Opportunities for Xenetic Biosciences and Neximmune

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between Xenetic and Neximmune is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Xenetic Biosciences and Neximmune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neximmune and Xenetic Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xenetic Biosciences are associated (or correlated) with Neximmune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neximmune has no effect on the direction of Xenetic Biosciences i.e., Xenetic Biosciences and Neximmune go up and down completely randomly.

Pair Corralation between Xenetic Biosciences and Neximmune

Given the investment horizon of 90 days Xenetic Biosciences is expected to generate 10.84 times less return on investment than Neximmune. But when comparing it to its historical volatility, Xenetic Biosciences is 3.17 times less risky than Neximmune. It trades about 0.01 of its potential returns per unit of risk. Neximmune is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  1,050  in Neximmune on August 27, 2024 and sell it today you would lose (807.00) from holding Neximmune or give up 76.86% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy79.78%
ValuesDaily Returns

Xenetic Biosciences  vs.  Neximmune

 Performance 
       Timeline  
Xenetic Biosciences 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Xenetic Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating forward indicators, Xenetic Biosciences may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Neximmune 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neximmune has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Neximmune is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Xenetic Biosciences and Neximmune Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Xenetic Biosciences and Neximmune

The main advantage of trading using opposite Xenetic Biosciences and Neximmune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xenetic Biosciences position performs unexpectedly, Neximmune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neximmune will offset losses from the drop in Neximmune's long position.
The idea behind Xenetic Biosciences and Neximmune pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Valuation
Check real value of public entities based on technical and fundamental data